Long term omeprazole therapy for reflux esophagitis: Follow-up in serum gastrin levels, EC cell hyperplasia and neoplasia

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

220

HTML

2371

Figures (1-3)

141

Tables (1-2)

118

Sum=2850

Dec 15, 2000 (publication date) through Apr 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Dec 15, 2000; 6(6): 789-792
Published online Dec 15, 2000. doi: 10.3748/wjg.v6.i6.789

Table 1 Type of treatment and sex distribution (n = 33)

Group	Number
Alternate day omeprazole therapy	7
Daily omeprazole therapy	26
Male patients	22
Female patients	11

Citation: Singh P, Indaram A, Greenberg R, Visvalingam V, Bank S. Long term omeprazole therapy for reflux esophagitis: Follow-up in serum gastrin levels, EC cell hyperplasia and neoplasia. World J Gastroenterol 2000; 6(6): 789-792
URL: https://www.wjgnet.com/1007-9327/full/v6/i6/789.htm
DOI: https://dx.doi.org/10.3748/wjg.v6.i6.789